Valeant Pharmaceuticals reported CAD685M in Selling and Administration Expenses for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Amgen AMGN:US $ 1.38B 130M
Ani Pharmaceuticals ANIP:US $ 18.82M 1.23M
Aphria Inc APH:CN C$ 74.04M 19.84M
Aurora Cannabis Inc ACB:CN 46.92M 1.04M
Biogen BIIB:US $ 637.3M 42.3M
Bristol Myers Squibb BMY:US $ 1.88B 215M
Canopy Growth Corp WEED:CN C$ 111.05M 38.77M
Catalent CTLT:US $ 184.1M 11.4M
Corcept Therapeutics CORT:US $ 30.03M 520K
Danaher DHR:US $ 1.97B 90M
Drreddys Laboratories RDY:US 13.75B 816M
Eli Lilly And LLY:US $ 1.69B 109.7M
Endo International Ordinary Shares ENDP:US 170.93M 12.7M
Gilead Sciences GILD:US $ 1.34B 297M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Horizon Pharma HZNP:US 355.2M 23.21M
JAZZ PHA JAZZ:US 429.03M 168.52M
Lannett LCI:US $ 21.58M 3.94M
Nektar Therapeutics NKTR:US $ 29.56M 2.12M
Pacira Pharmaceuticals PCRX:US $ 50.81M 2.29M
Perrigo Ordinary Shares PRGO:US 271.9M 3M
Phibro Animal Health PAHC:US $ 50.67M 1.64M
Prestige Brands PBH:US $ 61.91M 1.67M
Revance Therapeutics RVNC:US $ 49.01M 937K
Supernus Pharmaceuticals SUPN:US $ 69.54M 8.08M
Valeant Pharmaceuticals VRX:CN C$ 685M 79M
Vertex Pharmaceuticals VRTX:US $ 194.67M 2.59M
Zoetis ZTS:US $ 495M 86M